N/A (SANOFICONR)
Healthcare | Drug Manufacturers - General
₹5430.0
3.06% (₹161.4)
Market Overview
| Market Cap | 125056155648 |
| Volume | 7137 |
| 52W High | ₹5520.0 |
| 52W Low | ₹4211.55 |
Key Ratios
| P/E Ratio | 74.14993 |
| EPS | 73.23 |
| Beta | 0 |
| Dividend Yield | 1.04% |
Financial Performance
Revenue Growth
-0.221%
Profit Margin
0.24915001%
ROE
0%
ROA
0%
Stock Analysis Score: 40/100
Growth Score: 40/100
Key Strengths:
- Excellent profit margins above 15%
- Low volatility with beta below 1
- Strong operating margins above 15%
Recommendation
Hold - The stock shows mixed signals, monitor for improvements
Detailed Analysis
Growth: -0.2% revenue growth indicates weak business expansion.
Profitability: 24.9% profit margin shows excellent operational efficiency.
Returns: ROE of 0.0% demonstrates moderate return on shareholder investment.
Valuation: PE ratio of 74.1x is expensive compared to market averages.
Trading Decision Guide
- Score 80-100: Consider for long-term investment with high conviction
- Score 60-79: Suitable for medium-term investment with regular monitoring
- Score 40-59: Short-term trading opportunities, maintain strict stop-losses
- Score Below 40: High-risk trading only, thorough research essential
Risk Factors
- Market Cap: ₹12505.6Cr
- Beta: 0.00 (Market Volatility)
- 52-Week Range: ₹4211.6 - ₹5520.0
Last Updated: 2025-06-03 05:37:15